Assessing the Clinical Impact of Arthrosamid on Medial-Compartment Knee Osteoarthritis: Mechanisms, Efficacy, Safety and Future Directions
Arthrosamid® is a novel polyacrylamide hydrogel injection offering targeted, long-lasting relief for medial-compartment knee osteoarthritis, affecting millions worldwide. Unlike traditional treatments, Arthrosamid® delivers mechanical cushioning and improved joint lubrication through a single outpatient procedure, reducing pain and enhancing mobility. Clinical studies report significant symptom improvement lasting up to two years with minimal side effects, bridging the gap between medication and surgery. Ideal for patients unresponsive to conservative therapies, Arthrosamid® supports knee stability and quality of life. Ongoing research aims to validate long-term benefits and explore synergy with regenerative treatments, making Arthrosamid® a promising advancement in osteoarthritis care.
